WAT · Healthcare · $41.8B
$425.71-3.11%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
7/'26 vs prev quarter
Among 39 Medical - Diagnostics & Research peers
Quarterly Revenue Growth
“이번 분기 유기적 매출이 통화 기준 +9%로 가이던스 상단을 100bp 넘어섰고, 인수한 BD 사업부는 1분기 완전 편입 첫 분기에 +4% 성장”
In the company's words · 2026 2분기 earnings call